Skip to content

Head to head

GentleMax Pro Plus vs Motus AZ+ (2026)

Compare purchase costs, running costs and the evidence behind each device.

Read the comparison overview
Purchase cost
The catalog lists $120k–$160k for Motus AZ+. No new-price range is on file for GentleMax Pro Plus. Check the source notes and request current quotes.
Practice fit
GentleMax Pro Plus: alexandrite + nd:yag. Motus AZ+: dual-wavelength (in-motion). Check each model’s US regulatory status and labeled indications for your intended use.

Alexandrite + Nd:YAG

View full device profile →

Dual-wavelength (in-motion)

View full device profile →

Price comparison

New price range

Candela GentleMax Pro Plus
Not published
DEKA Motus AZ+
$120k–$160kSource not documented

Used price reference

Candela GentleMax Pro Plus
Not published
DEKA Motus AZ+
$80k–$110kSource not documented

Payback calculator

Candela GentleMax Pro Plus
View cost details
DEKA Motus AZ+
View ROI calculator

Next step

Candela GentleMax Pro Plus
DEKA Motus AZ+

Supplies & running costs

Supplies & restrictions

Candela GentleMax Pro Plus
Read supply costs & requirements

DCD cooling uses replacement cryogen containers. Candela also offers an optional Air Cooling Compatible (ACC) delivery system. Ask for a supply and replacement-parts quote for your exact handpiece and cooling configuration. Per-treatment and annual supply costs have not been verified here.

Manufacturer-provided · Sep 19, 2026

View running-cost details
DEKA Motus AZ+

No per-treatment consumables — gel and eventual sapphire-tip wear; a few thousand a year in maintenance reserve.

Source not documented

View running-cost details

FDA status & indications

FDA status & indication

Candela GentleMax Pro Plus
FDA record cited — see scopeK201111, K112715, K133283

Record scope: Temporary improvement in clear nail is not an indication for curing nail fungus. Follow wavelength-specific labeling; later GLX accessories are not automatically established by this record.

Read FDA indication wording
“755nm: Temporary hair reduction. Stable long-term or permanent reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as long-term stable reduction in the number of hairs regrowing after a treatment regime. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. On all skin types (Fitzpatrick I-VI) including tanned skin. Treatment of benign pigmented lesions. Treatment of wrinkles. The photocoagulation of dermatological vascular lesions (such as port-wine stains, hemangiomas, telangiectasias). 1064nm: Removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of PFB. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The lasers are indicated on all skin types Fitzpatrick I-VI including tanned skin. Photocoagulation and hemostasis of pigmented and vascular lesions such as but not limited to port wine stains, hemangioma, warts, telangiectasia, rosacea, venous lake, leg veins and spider veins. Coagulation and hemostasis of soft tissue. Benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sun spots), cafe au lait macules, seborrheic keratosis, nevi, chloasma, verrucae, skin tags, keratosis, tattoos (significant reduction in the intensity of black and/or blue-black tattoos) and plaques. The laser is indicated for pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. Treatment of wrinkles. Temporary increase of clear nail in patients with onychomycosis (e.g., dermatophytes, Trichophyton rubrum and T. mentagrophytes, and/or yeast Candida Albicans, etc.)”
DEKA Motus AZ+
FDA record cited — see scopeK211821, K162886, K181486

Record scope: K211821 identifies DEKA Motus AZ, applicant El.En Electronic Engineering SPA. The catalog’s AZ+ suffix is a configuration/generation claim requiring US labeling confirmation.

Read FDA indication wording
“Alexandrite 755nm laser source: Temporary hair reduction. Stable long-term or permanent hair reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6,9, and 12 months after the completion of a treatment regime, on all skin types (Fitzpatrick I – VI) including tanned skin. Treatment of benign pigmented lesions. Treatment of wrinkles. Photocoagulation of benign dermatological vascular lesions (such as port-wine stains, hemangiomas, telangiectasias). Nd:YAG 1064nm laser source: Removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of PFB. The lasers are indicated on all Skin Types Fitzpatrick I-VI including tanned skin. Photocoagulation and hemostasis of benign pigmented and benign vascular lesions, such as but not limited to port wine stains, hemangioma, warts, teleangiectasia, rosacea, venus lake, leg veins and spider veins. Coagulation and hemostasis of soft tissue. Benign pigmented lesions such as, but not limited to, lentigos, (age spots), solar lentigos (sun spots), cafe au lait macules, seborrheic keratosis, nevi, cloasma, verrucae, skin tags, keratosis and plaques. The laser is indicated for benign pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. The laser is also indicated for the reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. Treatment of wrinkles.”

Which chains run each

Chain adoption

Candela GentleMax Pro Plus
3 recorded pairings
DEKA Motus AZ+
0 recorded pairings

Chains using it

Candela GentleMax Pro Plus
  • Ideal Image(Confirmed)
  • SEV Laser(Reported)
  • European Wax Center(Confirmed)
DEKA Motus AZ+
—

Approved reviews

Candela GentleMax Pro Plus
0
DEKA Motus AZ+
0

Specs and platform

Manufacturer

Candela GentleMax Pro Plus
Candela
DEKA Motus AZ+
DEKA

Built by (OEM)

Candela GentleMax Pro Plus
Candela Corporation
DEKA Motus AZ+
DEKA M.E.L.A. S.r.l.

Category

Candela GentleMax Pro Plus
Alexandrite + Nd:YAG
DEKA Motus AZ+
Dual-wavelength (in-motion)

Technology

Candela GentleMax Pro Plus
Dual 755nm alexandrite + 1064nm Nd:YAG (Alexandrite)
DEKA Motus AZ+
755 nm alexandrite + 1064 nm Nd:YAG with Moveo delivery (Alexandrite)

Launch year

Candela GentleMax Pro Plus
2021
DEKA Motus AZ+
2022

Status

Candela GentleMax Pro Plus
Current
DEKA Motus AZ+
Current

Manufacturing relationship evidence

Candela GentleMax Pro Plus
No separate manufacturing-relationship record linked.
DEKA Motus AZ+
No separate manufacturing-relationship record linked.

Current alternatives

Current catalog models in related categories. Confirm availability and configuration with the supplier.

No current alternatives identified in the catalog yet. Browse current models

Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.